SAM
SNDX icon

Smartleaf Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Smartleaf Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58K Sell
2,579
-80
-3% -$1.74K ﹤0.01% 1382
2025
Q4 		$55.1K Buy
2,659
+2,564
+2,699% +$44.7K ﹤0.01% 1501
2025
Q3 		$1.48K Buy
95
+44
+86% +$576 ﹤0.01% 2679
2025
Q2 		$461 Sell
51
-581
-92% -$6.39K ﹤0.01% 2602
2025
Q1 		$8.33K Buy
632
+15
+2% +$212 ﹤0.01% 1997
2024
Q4 		$7.72K Buy
617
+122
+25% +$2.09K ﹤0.01% 2090
2024
Q3 		$9.35K Buy
495
+242
+96% +$5K ﹤0.01% 1794
2024
Q2 		$5.14K Buy
253
+228
+912% +$4.77K ﹤0.01% 1792
2024
Q1 		$576 Buy
+25
New +$558 ﹤0.01% 1720

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Smartleaf Asset Management's SNDX Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Syndax Pharmaceuticals (SNDX) stake by 3% in Q1 2026, selling an estimated $1.74K and leaving 2,579 shares worth $58K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Smartleaf Asset Management first reported a position in SNDX in Q1 2024 and has held it in 9 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Smartleaf Asset Management held 2,579 shares of Syndax Pharmaceuticals worth $58K as of Q1 2026.
  • Smartleaf Asset Management sold 80 Syndax Pharmaceuticals shares in Q1 2026, an estimated $1.74K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1382 holding.
  • Smartleaf Asset Management first reported a position in Syndax Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.